BPMC
Blueprint Medicines Corp
Price:  
102.39 
USD
Volume:  
551,246.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC EV/EBITDA

-199.0%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -15.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 6,557.18 mil USD. BPMC's TTM EBITDA according to its financial statements is -429.56 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.5x - 15.1x 12.2x
Forward P/E multiples 14.1x - 23.8x 16.8x
Fair Price (98.71) - (105.41) (101.34)
Upside -196.4% - -203.0% -199.0%
102.39 USD
Stock Price
(101.34) USD
Fair Price

BPMC EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 -15.26
2024-05-22 -15.31
2024-05-21 -15.45
2024-05-20 -15.54
2024-05-17 -15.64
2024-05-16 -15.89
2024-05-15 -15.91
2024-05-14 -15.71
2024-05-13 -16.09
2024-05-10 -15.90
2024-05-09 -16.13
2024-05-08 -16.20
2024-05-07 -16.17
2024-05-06 -15.83
2024-05-03 -15.97
2024-05-02 -15.94
2024-05-01 -14.16
2024-04-30 -13.65
2024-04-29 -13.91
2024-04-26 -13.89
2024-04-25 -13.56
2024-04-24 -13.78
2024-04-23 -13.79
2024-04-22 -13.54
2024-04-19 -12.99
2024-04-18 -13.29
2024-04-17 -13.22
2024-04-16 -12.88
2024-04-15 -12.75
2024-04-12 -13.05
2024-04-11 -13.78
2024-04-10 -13.52
2024-04-09 -13.77
2024-04-08 -13.68
2024-04-05 -13.69
2024-04-04 -13.55
2024-04-03 -13.78
2024-04-02 -13.68
2024-04-01 -14.39
2024-03-28 -14.16
2024-03-27 -14.15
2024-03-26 -13.41
2024-03-25 -13.19
2024-03-22 -13.02
2024-03-21 -13.46
2024-03-20 -13.20
2024-03-19 -13.16
2024-03-18 -12.99
2024-03-15 -13.53
2024-03-14 -13.12